CIK 0001847367 · <br>Emerging growth company
ALUMIS INC.
Sign in to watch- Ticker
- ALMS
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- 650-231-6625
- Business address
- 280 EAST GRAND AVENUE, SOUTH SAN FRANCISCO, CA, 94080
- Former names
- FL2021-001, Inc.
- 425 Deal Prospectus/Communication re Business Combination
- 424B3 Offering Prospectus
- 4 Open-market buy Director bought 18,404 shares at an average $7.04 ($129,544)
- 4 Open-market buy President, CEO and Chairman bought 15,650 shares at $6.44 ($100,733)
- CORRESP Other Correspondence Between Filers and SEC Staff
- S-4/A Deal Registration Statement - Business Combination
- S-4 Deal Registration Statement - Business Combination
- 425 Deal Prospectus/Communication re Business Combination
- 8-K Event Other events
- S-8 Other Securities Offered to Employees in Benefit Plans
- 425 Deal Prospectus/Communication re Business Combination
- 10-K Report Annual Report
- 8-K Event Results of operations
- 8-K Event Other events
- 425 Deal Prospectus/Communication re Business Combination
- 425 Deal Prospectus/Communication re Business Combination
- 8-K Event Other events
- 425 Deal Prospectus/Communication re Business Combination
- 425 Deal Prospectus/Communication re Business Combination
- 8-K Event Regulation FD disclosure
Page 8 of 13 · 250 filings